Astellas Pharma | 4503 - Selling And Administration Expenses


Astellas Pharma reported JPY215.07B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Astellas Pharma JPY 215.07B 19.63B Jun/2026
Chugai Pharma JPY 29.04B 143M Jun/2026
Daiichi Sankyo JPY 249.96B 21.73B Jun/2026
Eisai JPY 114.83B 4.71B Jun/2026
Kyowa Hakko Kirin JPY 43.74B 2.66B Jun/2026
M3 JPY 27.81B 979M Jun/2026
Otsuka Holdings JPY 274.44B 14.95B Jun/2026
Shionogi JPY 45.15B 7.11B Jun/2026
Sumitomo Dainippon JPY 39.24B 3.82B Jun/2026
Takeda JPY 286.51B 5.48B Jun/2026
Terumo JPY 109.7B 5.11B Jun/2026